Skip to content

Gene Therapy

We believe with the work that Nationwide Children’s Hospital has already done, coupled with our commitment, there is a real chance Columbus, could become the most important place in the world for gene therapy development.
Doug Ingram -
President and CEO, Sarepta

Home to Leaders in Gene Therapy

Gene Therapy News in Ohio

Nationwide Children’s Hospital has strategically developed a fully integrated, early-stage gene therapy R&D capability, and, as a result, is truly differentiated in the emerging gene therapy sector. NCH is making a positive impact in the lives of patients worldwide.
Michael Triplett, PhD  -
Chief Executive Officer, Myonexus

Sarepta Therapeutics Chooses Ohio

Consider the following aspects of Ohio’s growing gene therapy ecosystem:

Ohio’s Healthcare Mission

Contact a Team Member